101 related articles for article (PubMed ID: 28668837)
1. Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.
Bolger GT; Licollari A; Tan A; Greil R; Vcelar B; Majeed M; Helson L
Anticancer Res; 2017 Jul; 37(7):3483-3492. PubMed ID: 28668837
[TBL] [Abstract][Full Text] [Related]
2. Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.
Bolger GT; Licollari A; Tan A; Greil R; Pleyer L; Vcelar B; Majeed M; Sordillo P
Anticancer Res; 2018 Jan; 38(1):121-130. PubMed ID: 29277764
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger GT; Licollari A; Tan A; Greil R; Vcelar B; Greil-Ressler S; Weiss L; Schönlieb C; Magnes T; Radl B; Majeed M; Sordillo PP
Cancer Chemother Pharmacol; 2019 Feb; 83(2):265-275. PubMed ID: 30430227
[TBL] [Abstract][Full Text] [Related]
4. Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells.
Bolger GT; Licollari A; Bagshaw R; Tan A; Greil R; Vcelar B; Majeed M; Sordillo P
Anticancer Res; 2019 Mar; 39(3):1161-1168. PubMed ID: 30842145
[TBL] [Abstract][Full Text] [Related]
5. Infusion pharmacokinetics of Lipocurc™ (liposomal curcumin) and its metabolite tetrahydrocurcumin in Beagle dogs.
Helson L; Bolger G; Majeed M; Vcelar B; Pucaj K; Matabudul D
Anticancer Res; 2012 Oct; 32(10):4365-70. PubMed ID: 23060560
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution of (Lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogs.
Matabudul D; Pucaj K; Bolger G; Vcelar B; Majeed M; Helson L
Anticancer Res; 2012 Oct; 32(10):4359-64. PubMed ID: 23060559
[TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans.
Storka A; Vcelar B; Klickovic U; Gouya G; Weisshaar S; Aschauer S; Bolger G; Helson L; Wolzt M
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):54-65. PubMed ID: 25500488
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of curcumin through reduction and glucuronidation in mice.
Pan MH; Huang TM; Lin JK
Drug Metab Dispos; 1999 Apr; 27(4):486-94. PubMed ID: 10101144
[TBL] [Abstract][Full Text] [Related]
9. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
[TBL] [Abstract][Full Text] [Related]
10. Use of basic mobile phase to improve chromatography and boost sensitivity for quantifying tetrahydrocurcumin in human plasma by LC-MS/MS.
Tan A; Wu Y; Wong M; Licollari A; Bolger G; Fanaras JC; Shopp G; Helson L
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():86-93. PubMed ID: 27327398
[TBL] [Abstract][Full Text] [Related]
11. Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug platform.
Chiu S; Terpstra KJ; Bureau Y; Hou J; Raheb H; Cernvosky Z; Badmeav V; Copen J; Husni M; Woodbury-Farina M
J Complement Integr Med; 2013 Nov; 10():. PubMed ID: 24200537
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Study of a Liposomal Curcumin Formulation (Lipocurc™): Toxicity and Biological Activity in Synovial Fibroblasts and Macrophages.
Kloesch B; Gober L; Loebsch S; Vcelar B; Helson L; Steiner G
In Vivo; 2016; 30(4):413-9. PubMed ID: 27381602
[TBL] [Abstract][Full Text] [Related]
13. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats.
Murugan P; Pari L
J Ethnopharmacol; 2007 Sep; 113(3):479-86. PubMed ID: 17693046
[TBL] [Abstract][Full Text] [Related]
14. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.
Liu A; Lou H; Zhao L; Fan P
J Pharm Biomed Anal; 2006 Feb; 40(3):720-7. PubMed ID: 16316738
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of TurmiZn, a Metallic Complex of Curcuminoids-Tetrahydrocurcumin and Zinc on Bioavailability, Antioxidant, and Cytokine Modulation Capability.
DuBourdieu D; Talukder J; Srivastava A; Lall R; Panchal S; Kothari C; Gupta RC
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838654
[TBL] [Abstract][Full Text] [Related]
16. Effect of liposomal curcumin on red blood cells in vitro.
Storka A; Vcelar B; Klickovic U; Gouya G; Weisshaar S; Aschauer S; Helson L; Wolzt M
Anticancer Res; 2013 Sep; 33(9):3629-34. PubMed ID: 24023289
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of liposomal curcumin cytochrome p450 metabolism.
Mach CM; Chen JH; Mosley SA; Kurzrock R; Smith JA
Anticancer Res; 2010 Mar; 30(3):811-4. PubMed ID: 20393001
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrocurcumin induces G2/M cell cycle arrest and apoptosis involving p38 MAPK activation in human breast cancer cells.
Kang N; Wang MM; Wang YH; Zhang ZN; Cao HR; Lv YH; Yang Y; Fan PH; Qiu F; Gao XM
Food Chem Toxicol; 2014 May; 67():193-200. PubMed ID: 24593988
[TBL] [Abstract][Full Text] [Related]
19. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA.
Yodkeeree S; Garbisa S; Limtrakul P
Acta Pharmacol Sin; 2008 Jul; 29(7):853-60. PubMed ID: 18565284
[TBL] [Abstract][Full Text] [Related]
20. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
